JNJ
Johnson & Johnson
NYSE: JNJ · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$229.85
+1.10% today
Updated 2026-04-29
Market cap
$547.28B
P/E ratio
26.31
P/S ratio
5.68x
EPS (TTM)
$8.64
Dividend yield
2.28%
52W range
$142 – $252
Volume
8.0M
Johnson & Johnson (JNJ) Financial statements
SEC filings — annual and quarterly data.
Profit margin
21.80%
Operating margin
27.40%
ROE
26.40%
ROA
8.42%
Debt/equity
0.59x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $53.32B | $11.05B | 71.76% | 25.71% | 20.73% |
| 2007 | $61.09B | $10.58B | 70.95% | 24.90% | 17.31% |
| 2008 | $63.75B | $12.95B | 70.96% | 25.36% | 20.31% |
| 2009 | $61.90B | $12.27B | 70.20% | 26.92% | 19.82% |
| 2010 | $61.59B | $13.33B | 69.49% | 26.84% | 21.65% |
| 2011 | $65.03B | $9.67B | 68.69% | 24.84% | 14.87% |
| 2012 | $67.22B | $10.85B | 67.78% | 25.34% | 16.14% |
| 2013 | $71.31B | $13.83B | 68.67% | 26.58% | 19.40% |
| 2014 | $74.33B | $16.32B | 69.40% | 28.44% | 21.96% |
| 2015 | $70.07B | $15.41B | 69.27% | 26.10% | 21.99% |
| 2016 | $71.89B | $16.54B | 69.69% | 29.06% | 23.01% |
| 2017 | $76.45B | $1.30B | 66.72% | 24.72% | 1.70% |
| 2018 | $81.58B | $15.30B | 66.79% | 25.96% | 18.75% |
| 2019 | $82.06B | $15.12B | 66.42% | 25.55% | 18.42% |
| 2020 | $82.58B | $14.71B | 65.58% | 23.89% | 17.82% |
| 2021 | $78.74B | $20.88B | 70.28% | 26.60% | 26.52% |
| 2022 | $79.99B | $17.94B | 69.25% | 26.27% | 22.43% |
| 2023 | $85.16B | $35.15B | 68.59% | 25.66% | 41.28% |
| 2024 | $88.82B | $14.07B | 69.07% | 24.94% | 15.84% |
| 2025 | $94.19B | $26.80B | 72.78% | 27.17% | 28.46% |